Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Clinical trial NCT00175955 · COMPLETED

Trial details

NCT number: NCT00175955
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dyskinesia, Medication-induced

Start date: 2005-05-01
Primary completion: 2005-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.